期刊文献+

Synthesis and biological evaluation of a series of novel salicylanilides as inhibitors of EGFR protein tyrosine kinases 被引量:2

Synthesis and biological evaluation of a series of novel salicylanilides as inhibitors of EGFR protein tyrosine kinases
原文传递
导出
摘要 The synthesis and biological evaluation of two series of salicylanilide derivatives on the EGFR and ErbB-2 tyrosine kinases inhibitory activities were conducted.Of the tested compounds those having an additional aryl group substituted on the anilino ring were active on the EGFR tyrosine kinase inhibition(7a-c and 13a,13c,13d,13f).The inhibitory activities were all in the low micromolar or submicromolar range.In addition,compound 13a was found to have dual inhibitory activities both on EGFR and ErbB-2 tyrosine kinases(1.654±1.280 and 7.134±1.265μmol/L). The synthesis and biological evaluation of two series of salicylanilide derivatives on the EGFR and ErbB-2 tyrosine kinases inhibitory activities were conducted.Of the tested compounds those having an additional aryl group substituted on the anilino ring were active on the EGFR tyrosine kinase inhibition(7a-c and 13a,13c,13d,13f).The inhibitory activities were all in the low micromolar or submicromolar range.In addition,compound 13a was found to have dual inhibitory activities both on EGFR and ErbB-2 tyrosine kinases(1.654±1.280 and 7.134±1.265μmol/L).
出处 《Chinese Chemical Letters》 SCIE CAS CSCD 2012年第5期529-532,共4页 中国化学快报(英文版)
基金 supported by the Research Fund for the Doctoral Program of Higher Education of China(No 20100071120051) the Fundamental Research Funds for the Central Universities(No10FX061)
关键词 Salicylanilides EGFR HER2 Tyrosine kinase inhibitor Salicylanilides EGFR HER2 Tyrosine kinase inhibitor
  • 相关文献

参考文献34

  • 1C.T.Supuran,A.Scozzafava. Protein tyrosine kinase inhibitors as anticancer agents[J].Expert Opinion on Therapeutic Patents,2004,(1):35.doi:10.1517/13543776.14.1.35.
  • 2Y.Yarden,M.X.Sliwkowski. Untangling the ErbB signalling network.[J].Nat Rev Mol Biol,2001,(2):127.doi:10.1038/35052073.
  • 3J.B.Johnston;S.Navaratnam;M.W.Pitz.查看详情[J],Current Medicinal Chemistry20063483.
  • 4P.A.Bunn Jr;B.Helfrich;A.F.Soriano.查看详情[J],Clinical Cancer Research20013239.
  • 5R.S.Herbst;A.B.Sandler.查看详情[J],Clinical Lung Cancer2004(Suppl.1):S7.
  • 6E.Raymond;S.Faivre;J.P.Arnand.查看详情[J],Drugs200015.
  • 7A.Levitzki,A.Gazit. TYROSINE KINASE INHIBITION - AN APPROACH TO DRUG DEVELOPMENT [Review][J].Science,1995,(5205):1782.doi:10.1126/science.7892601.
  • 8E.K.Rowinsky.查看详情[J],Annual Review of Medicine2004433.
  • 9J.Dumas.查看详情[J],Current Opinion in Drug Discovery and Development2001378.
  • 10H.C.Maguire Jr;M.I.Greene.查看详情[J],Seminars in Oncology1989148.

同被引文献11

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部